INSCIPROTEC is a companyResearch and development technology leads to innovationThe company was officially established in 2025. The company focuses on...Scientific validation and efficacy testing of vision care products.
In the current state of the eye care market, characterized by chaotic information and frequent disputes over product efficacy, the company aims to provide a professional, credible, and impartial verification mechanism to help consumers and businesses choose truly effective eye care products.
Team structure (personnel structure):
The team members of the Visual Health Innovation and Development Center primarily possess strong academic and industry backgrounds, and many members also hold positions within the Visual Health Innovation and Development Technology Alliance or the Visual Health Biotechnology Core Laboratory.
Team history (founding concept, award-winning experience, special introduction):
The core foundation of visual innovation can be traced back to The establishment of the core laboratory for visual health biotechnology in 2011Since then, the team has focused on visual health, continuously advancing eye care technology through research and collaboration.
The team has long been deeply involved in industry-academia collaboration. Projects include analyzing the preventative effects of *Cicada nymph* extract on corneal damage, evaluating the vision-protecting effects of camellia oil, and collaborating with multiple companies to evaluate the effects of lutein, Hangzhou white chrysanthemum, amniotic fluid stem cells, and probiotics on dry eye symptoms, reducing intraocular pressure, and alleviating pseudomyopia.
Project introduction:
The operation of visual innovation mainly revolves around four main axes:
1. Visual health certification mark.
2. Collaborative development of various eye care themes.
3. Partners in the development of new drugs for eye diseases.
4. Pet eye diseases and vision care.
To strengthen its R&D capabilities, the company plans to introduce...Phoenix M5 system (USA)(Equipped with five functions including fundus examination, slit lamp, ERG, OCT, and laser), this system can significantly accelerate the development of new drugs for macular and retinal diseases, elevating the company's R&D level to international standards.
